Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 25 (SLC25A25) is a mitochondrial transporter protein localized to the inner mitochondrial membrane. It functions predominantly as an antiporter for adenyl nucleotides, mediating the exchange of ATP-Mg and inorganic phosphate (Pi) and thereby regulating the mitochondrial pool of adenine nucleotides according to cellular energetic demands. SLC25A25 is a member of the mitochondrial carrier family (SLC25), which is the largest solute transporter family in humans. It plays a critical role in cellular energy homeostasis, with activity modulated by calcium binding. Dysfunction or mutation in SLC25A25 is associated with human diseases such as nephrolithiasis and combined oxidative phosphorylation deficiency, highlighting its importance in mitochondrial physiology and pathology[1][2][3][5][6].
Not applicable/unknown for drugs due to the absence of directly targeting compounds; mechanistically, SLC25A25 operates as an ATP-Mg/Pi antiporter in mitochondria, supporting nucleotide exchange essential for cellular energy management[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 25 (SLC25A25).